MBC Advocate, following MBC breakthroughs
Joined October 2022
- Tweets 5,014
- Following 1,086
- Followers 1,458
- Likes 15,716
219 Photos and videos
🚨 CALL TO ACTION: SAVE Metastatic Breast Cancer LIVES!
Sign the petition NOW! Every signature brings us one step closer to accelerating research, prioritizing MBC,and saving lives. Please sign and share. #AVCT @SecKennedy @POTUS @elonmusk @NIH @theNCI @VP
c.org/SQ9VRnGws4
3
538
Jun 3
Great News! “Today's data further underscores our confidence in both our Gen One product faridoxorubicin (AVA6000) and our pre|CISION® technology to significantly improve treatment options for cancer patients.” #AVCT #ASCO26 firstwordpharma.com/story/75…
1
23
1,603
May 29
BriaCell announced SIX clinical data presentations focused on advanced metastatic breast cancer, including:
Survival data for Bria-IMT™ CPI at 12 and 24 months. #ASCO26
2
227
May 29
Happy #ASCO26! Celcuity announced positive Phase 3 VIKTORIA-1 results for gedatolisib in HR /HER2- metastatic breast cancer with PIK3CA mutations after progression on CDK4/6 inhibitors.
2
249
May 29
Top 10 Metastatic Breast Cancer Abstracts to Watch at #ASCO26
ASCO 2026 is packed with potentially practice-changing data for Metastatic Breast Cancer.
1
4
233
May 1
Great News! Arvinas received FDA approval for VEPPANU (vepdegestrant), the first-ever PROTAC therapy, for ER /HER2-, ESR1-mutated advanced or metastatic breast cancer after prior endocrine therapy. $ARVN $PFE #ASCO26 ir.arvinas.com/news-releases…
1
5
1,263
Apr 22
Great News! “Presentation of additional analyses from FAP-Exd (AVA6103) study shows robust activity in PDX models with low FAP expression and more favorable kinetic profile compared to the marketed antibody-drug conjugate (ADC) Enhertu.” #AVCT #AACR26 globenewswire.com/news-relea…
1
6
45
2,893
Apr 20
Congrats Avacta! This is fantastic news!
Metastatic ER breast cancer is included, with expansion cohorts for AVA6103 planned in additional FAP cancers, including hormone receptor–positive breast cancer (HR BC). #AVCT #AACR26
Apr 20
#AVCT Big plans for AVA6103. Potentially 7 expansion cohorts. Some new indications added (see recent interview)
I wonder what changed between February and April
Expansion cohorts are planned in additional FAP cancers including hormone-receptor positive breast cancer (HR-BC), non-small cell lung cancer (NSCLC) and colorectal cancer (CRC)”
1
9
53
3,759
Apr 18
“Marengo Reports Initial Phase 2 Clinical Results for MBC. Encouraging Phase 2 clinical activity with confirmed complete responses observed in heavily pretreated metastatic breast cancer across both TNBC and HR /HER2- subtypes.” #AACR26 prnewswire.com/news-releases…
2
2
829
Apr 18
“SAGA Diagnostics to Present New Pathlight MRD Data for Metastatic Breast Cancer. Ultrasensitive, structural variant-based ctDNA monitoring reliably tracks therapeutic response and predicts progression in metastatic breast cancer.” #AACR26 marketwatch.com/press-releas…
2
2
286
Apr 18
“Metastatic breast cancer remains a challenge to manage clinically, and the use of an accurate complementary biomarker may help improve the care for our patients.” #AACR26 morningstar.com/news/busines…
1
1
2
197
Apr 13
“KRAS-mutant cell lines. BBO-11818 is currently being evaluated in the Phase1 KONQUER-101 trial in subjects with locally advanced unresectable or metastatic KRAS-mutant solid tumors.” $BBOT #AACR26 stocktitan.net/news/BBOT/bbo…
3
300
Apr 9
Healthcare decision-makers should take patient preferences into account by prioritizing innovative therapies and oral formulations to enhance efficacy and tolerability to improve outcomes and QoL in patients with metastatic breast cancer. #AACR26 esmoopen.com/article/S2059-7…
3
214
Apr 9
MBC has no cure. These findings highlight the unmet treatment needs and the importance of improving or maintaining QoL in the management of metastatic breast cancer. The majority of patients prefer to avoid chemotherapy as long as possible. #AACR26 esmoopen.com/article/S2059-7…
2
169
Apr 9
Unmet needs in metastatic breast cancer, overcoming endocrine resistance, improving adverse effect management, ensuring guideline-concordant care, addressing long-term toxicities, clinical trial integration, advancing the evolving CDK4/6 inhibitor. #AACR26 pharmacytimes.com/view/unmet…
2
156
Apr 9
There is a need for better access to up-to-date information pertaining to metastatic breast cancer treatment focusing on its side effects, pain management options and suitable clinical trials specifically on immunotherapy. #AACR26 pmc.ncbi.nlm.nih.gov/article…
2
120
Apr 9
Researchers say that in 2020, deaths from cancer, dominated by breast cancer, left 1,047,000 children without a mother. The findings highlight the need to accelerate metastatic breast cancer research and urgent need for a cure. #AACR26 aacrjournals.org/cancerdisco…
3
141
Apr 7
Metastatic breast cancer in developing resistance through mutations, receptor crosstalk, and downstream signaling disruptions is thoroughly examined. To combat multidrug resistance in MBC, several therapeutic strategies have been explored. #AACR26 sciencedirect.com/science/ar…
2
239